Literature DB >> 33887970

Surgical outcomes of modified capsular tension ring and intraocular lens implantation in Marfan syndrome with ectopia lentis.

Zexu Chen1,2,3, Min Zhang1,2,3, Michael Deng1,2,3, Tianhui Chen1,2,3, Jiahui Chen1,2,3, Jialei Zheng1,2,3, Yongxiang Jiang1,2,3.   

Abstract

OBJECTIVE: To evaluate surgical outcomes of modified capsular tension ring (MCTR) and intraocular lens (IOL) implantation in eyes of Marfan syndrome (MFS).
METHODS: This retrospective case series included MFS patients receiving MCTR transscleral fixation and IOL in-the-bag implantation. The MCTR was sutured to the sclera through a sulcus by 9-0 polypropylene with the modified knotless Z-suture technique. Main outcomes were visual acuity and postoperative complications.
RESULTS: A total of 109 MFS patients (187 eyes) had the surgery. Patients were 15.47 ± 14.36 years old and followed up for 10.07 ± 8.99 months. MCTR and IOL implantations were performed in 174 eyes (93.05%). The postoperative BCVA (LogMAR) was 0.24 ± 0.24 (1 month), 0.26 ± 0.20 (3 months), 0.22 ± 0.20 (6 months), 0.20 ± 0.19 (12 months) and 0.25 ± 0.32 (over 12 months), which was significantly better than preoperatively (0.63 ± 0.35) (p < 0.001). Major complications included posterior capsular opacification (PCO) in 41 eyes (23.56%) and decentered anterior capsular opacification (ACO) in 15 eyes (8.62%). The mean occurrence time was 9.44 ± 7.08 and 8.87 ± 15.08 months respectively. Other complications included transient intraocular pressure elevation in seven eyes (4.02%), retinal detachment in two eyes (1.15%), cystoid macula edema in one eye (0.57%), and endophthalmitis in one eye (0.57%). No eye had suture breakage or IOL dislocation.
CONCLUSIONS: The visual improvement is significant in eyes of MFS undergoing MCTR transscleral fixation and IOL in-the-bag implantation. The long-term monitoring of complications is warranted, especially in the first-two years.

Entities:  

Keywords:  Marfan syndrome; Modified capsular tension ring; anterior capsular opacification; posterior capsular opacification; visual acuity

Year:  2021        PMID: 33887970     DOI: 10.1177/11206721211012868

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  6 in total

1.  Factors Related to Visual Outcomes after Lens Surgery in Isolated Microspherophakia.

Authors:  Jialei Zheng; Lina Cheng; Zexu Chen; Tianhui Chen; Yongxiang Jiang
Journal:  J Ophthalmol       Date:  2022-06-15       Impact factor: 1.974

2.  Cysteine Substitution and Calcium-Binding Mutations in FBN1 cbEGF-Like Domains Are Associated With Severe Ocular Involvement in Patients With Congenital Ectopia Lentis.

Authors:  Min Zhang; Zexu Chen; Tianhui Chen; Xiaodong Sun; Yongxiang Jiang
Journal:  Front Cell Dev Biol       Date:  2022-02-14

3.  Phacoemulsification Combined With Supra-Capsular and Scleral-Fixated Intraocular Lens Implantation in Microspherophakia: A Retrospective Comparative Study.

Authors:  Ze-Xu Chen; Zhen-Nan Zhao; Yang Sun; Wan-Nan Jia; Jia-Lei Zheng; Jia-Hui Chen; Tian-Hui Chen; Li-Na Lan; Yong-Xiang Jiang
Journal:  Front Med (Lausanne)       Date:  2022-04-14

4.  Clinical profile and outcome of ocular manifestation in Marfans syndrome in India.

Authors:  Shreya Shah; Mehul Shah; Pradeep Chandane; Sakshi Makhloga; Deeksha Thorat; Meera Sanghani
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 2.969

5.  Outcomes of Transscleral Two-Point Fixation Versus Closed Continuous-Loop Four-Point Fixation of Intraocular Lens in Subluxated Lens Secondary to Marfan Syndrome.

Authors:  Xiang Gao; Wenting Zhu; Jingyi Tian; Xiaolei Sun; Ziyi Ni; Gongqiang Yuan; Jingjing Zhang
Journal:  Ophthalmol Ther       Date:  2022-05-20

6.  Treatment of long-term endophthalmitis developing after intraocular lens implantation in children: a retrospective study.

Authors:  Chen Zou; Ting Zhang; Xin Wang; Hong Zhuang; Rui Jiang
Journal:  BMC Ophthalmol       Date:  2022-07-12       Impact factor: 2.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.